INS and Hyperglycemia: GLP-1 receptor agonists stimulate glucose-medicated insulin secretion, suppress glucagon secretion, delay gastric emptying, and decrease appetite, thus explaining the considerable effect of these drugs on postprandial hyperglycemia and weight loss.